What is Revvity's life sciences — goodwill, acquisition?

Revvity (RVTY) reported life sciences — goodwill, acquisition of $32.04M in Q1 2026.

What does life sciences — goodwill, acquisition mean?

The excess purchase price paid for acquisitions in the Life Sciences segment.

How do you interpret life sciences — goodwill, acquisition?

An increase reflects active M&A strategy, while large write-downs could signal overpayment or poor integration performance.

How does life sciences — goodwill, acquisition compare across companies?

Standard balance sheet item for companies pursuing inorganic growth strategies.

Revvity RVTY Life Sciences — Goodwill, Acquisition

Other segment segments

Diagnostics

$0—

Similar metrics at other companies

ALife Sciences and Applied Markets — Goodwill

$1.58B+0.3%

WAT

WATBiosciences — Goodwill

$3.8B—

ALife Sciences and Diagnostics Markets — Goodwill

$3B-0.1%

DCILife Sciences Segment — Goodwill

$172.8M+2.2%

DCILife Sciences Segment — Goodwill acquired

$0—

PEA

PEAKLifescience — Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill

——

Other financials

Income statement

See full

Revenue$711.1M+7.0%

Gross profit$387.7M+3.2%

Operating income$75.9M+5.1%

Net income$40.7M-3.6%

EPS (diluted)$0.36+2.9%

Balance sheet

See full

Cash & equivalents$861.5M-24.3%

Total debt$3.9B+17.8%

Total equity$7.2B-5.9%

Total assets$12.0B-2.9%

Cash flow

See full

Operating cash flow$115.2M-10.1%

CapEx$19.8M+23.7%

Free cash flow$95.5M-14.9%

Valuation

See full

Market cap$11.16B-22.9%

Enterprise value$14.24B-13.7%

P/E46.5×-4.0×

P/S3.8×-1.4×

Profitability

See full

Gross margin48.5%—

Operating margin12.4%-1.1pp

Net margin8.3%-2.1pp

FCF margin17%-1.9pp

Returns & leverage

See full

Return on equity3.2%-0.5pp

Debt / equity0.5×+0.1×

Current ratio1.7×-1.9×

Where this comes from

Reported directly by Revvity in its filing.

Tagged under the XBRL concept revv:GoodwillAcquisition.

The official record: Revvity’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Revvity's life sciences — goodwill, acquisition.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Revvity's life sciences — goodwill, acquisition?: Revvity (RVTY) reported life sciences — goodwill, acquisition of $32.04M in Q1 2026.
What does life sciences — goodwill, acquisition mean?: The excess purchase price paid for acquisitions in the Life Sciences segment.
How do you interpret life sciences — goodwill, acquisition?: An increase reflects active M&A strategy, while large write-downs could signal overpayment or poor integration performance.
How does life sciences — goodwill, acquisition compare across companies?: Standard balance sheet item for companies pursuing inorganic growth strategies.